FORMULATION DEVELOPMENT AND EVALUATION OF OXYMORPHONE HCL SOFT GELATIN CAPSULES

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2019, Vol 6, Issue 10

Abstract

The objective of this work is to develop simple, elegant, liquid-filled immediate release soft gelatin capsules containing Oxymorphone HCl intended for the management of moderate to severe pain in patients who require treatment with an oral opioid analgesic. The present work describes the design of formulation and manufacturing process of Oxymorphone HCl 30 mg capsules. Manufacturing of Oxymorphone HCl Capsules, 30 mg, consists of two concurrent manufacturing processes: gel mass and fill material, which converge during the encapsulation process. Capsule fill material was formulated using tartaric acid and low molecular polyethylene glycol 400 matrix system. The gel mass was prepared in gelatin as shell forming material, and glycerin was used as plasticizer at a 1: 0.5 ratio. The prepared soft gelatin capsules were evaluated for water content in fill material, loss on drying of shell, weight variation, burst strength, assay, and dissolution. The capsules had a fill weight of 350 mg, disintegration time less than 10 minutes, and drug release rate >95% in 20 minutes. Furthermore, Texture analysis showed the capsules had burst strength of 145.0 N with an elasticity value of 3.03 mm. With this we, conclude that Oxymorphone HCl immediate release soft gelatin capsules can be manufactured at commercial scale with similar composition and improved quality attributes of other existing solid dosage forms such as tablets.

Authors and Affiliations

S. Gumudavelli

Keywords

Related Articles

PERCEPTIONS OF SATISFACTION SERVICES OF PATIENTS AT MEDICAL OPD SERVICES AT AYAAN INSTITUTE OF MEDICAL SCIENCES, HYDERABAD

Background: In spite of progress of information and technology, establishment of many medical and para medical institutes are coming up during these days throughout the globe. On the other hand population is increasing t...

ASSESSMENT OF NEUROLOGICAL TOXICITY OF GOLD SPHERE AND ROD NANOPARTICLES USED AS ADJUVANT TO RIFT VALLEY FEVER VIRUS VACCINE (RVFV) AND RELATED PHYSIOLOGICAL CHANGES: IN VIVO STUDY

Nanotechnology is a promising, rapidly growing discipline, and many research efforts have so far been focused on using nanoparticles as agents for targeted drug delivery. Although aluminum (Alum) salt is renowned as a va...

"THE POSSIBLE PROTECTIVE EFFECT OF OMEGA-3 AGAINST METOCLOPRAMIDE INDUCED HYPERLIPIDEMIA IN RATS"

Metoclopramide (MCA) is one of prokinetic drugs. It is used for the treatment upper gastrointestinal motility disorders such as diabetic gastroparesis, nausea, vomiting and gastroesophageal reflux. It increases serum pro...

ROLE OF SUB PUBIC ANGLE IN SEX ESTIMATION IN A NIGERIAN POPULATION

This study is aimed at determining sex using subpubic angle, which is one of the is most critical issues raised when an unknown human skeletal remains are found. The angle is measured by drawing two lines at the pubic ra...

THE RELATION OF COMMUNICATIONAL SKILLS AND QUALITY OF TREATMENT SERVICES (CASE STUDY: SHIRAZ CITY HOSPITALS, 2016)

The skill of communicating with the patient causes success in obtaining enough information from him, correct diagnosis, attracting the patient trust and finally his successful treatment. The aim of performing this study...

Download PDF file
  • EP ID EP671923
  • DOI -
  • Views 161
  • Downloads 0

How To Cite

S. Gumudavelli (2019). FORMULATION DEVELOPMENT AND EVALUATION OF OXYMORPHONE HCL SOFT GELATIN CAPSULES. European Journal of Biomedical and Pharmaceutical Sciences, 6(10), 43-45. https://europub.co.uk/articles/-A-671923